Loading...
Personalis, Inc.
PSNL•NASDAQ
Healthcare
Medical - Diagnostics & Research
$6.49
$-0.22(-3.28%)
Personalis, Inc. (PSNL) Financial Performance & Income Statement Overview
Review Personalis, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
15.15%
↑ 15.15%
Operating Income Growth
37.90%
↑ 37.90%
Net Income Growth
24.94%
↑ 24.94%
Operating Cash Flow Growth
19.74%
↑ 19.74%
Operating Margin
-78.28%
↓ 78.28%
Gross Margin
33.30%
↑ 33.30%
Net Profit Margin
-98.10%
↓ 98.10%
ROE
-48.78%
↓ 48.78%
ROIC
-27.56%
↓ 27.56%
Personalis, Inc. (PSNL) Income Statement & Financial Overview
Review Personalis, Inc.'s (PSNL) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $16.80M | $25.71M | $22.58M | $19.52M |
| Cost of Revenue | $12.25M | $16.96M | $14.54M | $14.03M |
| Gross Profit | $4.55M | $8.74M | $8.04M | $5.49M |
| Gross Profit Ratio | $0.27 | $0.34 | $0.36 | $0.28 |
| R&D Expenses | $11.49M | $11.68M | $12.96M | $12.77M |
| SG&A Expenses | $11.17M | $11.44M | $11.97M | $11.60M |
| Operating Expenses | $22.66M | $23.13M | $24.93M | $24.37M |
| Total Costs & Expenses | $34.91M | $40.09M | $39.47M | $38.41M |
| Interest Income | $1.63M | $1.38M | $1.14M | $1.36M |
| Interest Expense | $1000.00 | $7000.00 | $9000.00 | $9000.00 |
| Depreciation & Amortization | $2.54M | $2.76M | $2.80M | $2.84M |
| EBITDA | -$13.88M | -$36.32M | -$9.99M | -$10.12M |
| EBITDA Ratio | -$0.83 | -$1.41 | -$0.44 | -$0.52 |
| Operating Income | -$18.11M | -$14.38M | -$16.89M | -$18.88M |
| Operating Income Ratio | -$1.08 | -$0.56 | -$0.75 | -$0.97 |
| Other Income/Expenses (Net) | $1.69M | -$24.70M | $4.09M | $5.92M |
| Income Before Tax | -$16.42M | -$39.09M | -$12.80M | -$12.96M |
| Income Before Tax Ratio | -$0.98 | -$1.52 | -$0.57 | -$0.66 |
| Income Tax Expense | $4000.00 | $3000.00 | $4000.00 | $7000.00 |
| Net Income | -$16.43M | -$39.09M | -$12.80M | -$12.97M |
| Net Income Ratio | -$0.98 | -$1.52 | -$0.57 | -$0.66 |
| EPS | -$0.23 | -$0.64 | -$0.24 | -$0.26 |
| Diluted EPS | -$0.23 | -$0.64 | -$0.24 | -$0.26 |
| Weighted Avg Shares Outstanding | $72.88M | $61.05M | $52.39M | $50.68M |
| Weighted Avg Shares Outstanding (Diluted) | $72.88M | $61.05M | $52.39M | $50.68M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan